Roadmap to Nanomedical Applications: Nanotoxicology and In Vitro Guidelines for Lanthanide‐Doped Luminescence Nanothermometers
Advanced NanoBiomed Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 27, 2025
Lanthanide‐based
luminescence
nanothermometry
has
demonstrated
unprecedented
advantages
in
the
development
of
nanotheranostic
platforms
for
potential
medical
applications,
yet
despite
exponential
research
progress
and
great
enthusiasm
across
various
related
disciplines,
a
swift
bench‐to‐bedside
translation
seems
to
be
still
out
reach.
This
is
predominantly
fundamental
issues
at
preclinical
stage,
such
as
complex
nanomaterials
design,
incomplete
optimization,
fragmented
characterization,
insufficient
validation
nanothermometer
performance
physiological
environments.
The
main
impediments
currently
are
important
biophysicochemical
that
must
addressed
comprehensively,
first
foremost
available
vitro
systems,
before
going
on
vivo
investigations.
review
outlines
critical
perspective,
well
route
suggestions
underexplored
aspects
address
significantly
minimize
existing
translational
gap.
Language: Английский
Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: May 3, 2025
Pyroptosis
is
a
distinct
form
of
programmed
cell
death
characterized
by
the
rupture
membrane
and
robust
inflammatory
responses.
Increasing
evidence
suggests
that
pyroptosis
significantly
affects
tumor
microenvironment
antitumor
immunity
releasing
damage-associated
molecular
patterns
(DAMPs)
pro-inflammatory
mediators,
thereby
establishing
it
as
pivotal
target
in
cancer
immunotherapy.
This
review
thoroughly
explores
mechanisms
underlying
pyroptosis,
with
particular
focus
on
inflammasome
activation
gasdermin
family
proteins
(GSDMs).
It
examines
role
pyroptotic
reshaping
immune
(TIME)
involving
both
cells,
discusses
recent
advancements
targeting
pathways
through
therapeutic
strategies
such
small
molecule
modulators,
engineered
nanocarriers,
combinatory
treatments
checkpoint
inhibitors.
We
also
advances
future
directions
to
enhance
immunotherapy
inhibitors,
adoptive
therapy,
vaccines.
study
suggested
offers
promising
avenue
amplify
responses
surmount
resistance
existing
immunotherapies,
potentially
leading
more
efficacious
treatments.
Language: Английский